These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 16782443

  • 21. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO.
    Cancer Res; 2005 Nov 01; 65(21):9789-98. PubMed ID: 16267000
    [Abstract] [Full Text] [Related]

  • 22. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B, Zhang Y, Luo G, Li L, Zhang J.
    Anat Rec (Hoboken); 2009 May 01; 292(5):633-9. PubMed ID: 19382240
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
    Adachi Y, Nakamura H, Kitamura Y, Taniguchi Y, Araki K, Shomori K, Horie Y, Kurozawa Y, Ito H, Hayashi K.
    Pathol Int; 2007 Apr 01; 57(4):171-7. PubMed ID: 17316411
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Role of vascular endothelial growth factor-C and -D mRNA in breast cancer.
    Teramoto S, Arihiro K, Koseki M, Kataoka T, Asahara T, Ohdan H.
    Hiroshima J Med Sci; 2008 Jun 01; 57(2):73-8. PubMed ID: 18717190
    [Abstract] [Full Text] [Related]

  • 30. Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site.
    van der Schaft DW, Pauwels P, Hulsmans S, Zimmermann M, van de Poll-Franse LV, Griffioen AW.
    Cancer Lett; 2007 Aug 28; 254(1):128-36. PubMed ID: 17442484
    [Abstract] [Full Text] [Related]

  • 31. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
    Li YS, Kaneko M, Amatya VJ, Takeshima Y, Arihiro K, Inai K.
    Pathol Int; 2006 May 28; 56(5):256-61. PubMed ID: 16669874
    [Abstract] [Full Text] [Related]

  • 32. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.
    Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M.
    Nat Med; 2001 Feb 28; 7(2):192-8. PubMed ID: 11175850
    [Abstract] [Full Text] [Related]

  • 33. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
    Yu XM, Lo CY, Chan WF, Lam KY, Leung P, Luk JM.
    Clin Cancer Res; 2005 Nov 15; 11(22):8063-9. PubMed ID: 16299237
    [Abstract] [Full Text] [Related]

  • 34. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
    Jennbacken K, Vallbo C, Wang W, Damber JE.
    Prostate; 2005 Oct 01; 65(2):110-6. PubMed ID: 15880525
    [Abstract] [Full Text] [Related]

  • 35. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.
    Van der Auwera I, Van Laere SJ, Van den Eynden GG, Benoy I, van Dam P, Colpaert CG, Fox SB, Turley H, Harris AL, Van Marck EA, Vermeulen PB, Dirix LY.
    Clin Cancer Res; 2004 Dec 01; 10(23):7965-71. PubMed ID: 15585631
    [Abstract] [Full Text] [Related]

  • 36. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis.
    Nakamura Y, Yasuoka H, Tsujimoto M, Yoshidome K, Nakahara M, Nakao K, Nakamura M, Kakudo K.
    Clin Cancer Res; 2006 Feb 15; 12(4):1201-7. PubMed ID: 16489074
    [Abstract] [Full Text] [Related]

  • 37. Vascular endothelial growth factor-C expression in bladder transitional cell cancer and its relationship to lymph node metastasis.
    Zu X, Tang Z, Li Y, Gao N, Ding J, Qi L.
    BJU Int; 2006 Nov 15; 98(5):1090-3. PubMed ID: 17034609
    [Abstract] [Full Text] [Related]

  • 38. [Expression of vascular endothelial growth factor A and C in human breast cancer and their significance].
    Hu SE, Zhang YJ, Cui YM, Zhang HQ.
    Ai Zheng; 2005 Sep 15; 24(9):1076-9. PubMed ID: 16159428
    [Abstract] [Full Text] [Related]

  • 39. [Expression of VEGF-C and angiogenesis, and lymphangiogenesis in papillary thyroid carcinoma].
    Liang QC, Wei QY, Fan SQ.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun 15; 31(3):414-6, 419. PubMed ID: 16859137
    [Abstract] [Full Text] [Related]

  • 40. Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up.
    Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Tsukiyama A, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K.
    Mod Pathol; 2003 Apr 15; 16(4):309-14. PubMed ID: 12692195
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.